Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Director departure
Quarterly results
CC transcript
|
|
EPIRUS Biopharmaceuticals, Inc. (EPRS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/31/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/31/2016 |
4
| Wyand Michael (President and COO) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.|
Txns:
| Granted 280,000 restricted stock units
@ $0 |
|
| 05/31/2016 |
4
| Aurentz Vincent (Chief Business Officer) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.|
Txns:
| Granted 230,000 restricted stock units
@ $0 |
|
| 05/31/2016 |
4
| Ticktin Robert (General Counsel) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.|
Txns:
| Granted 230,000 restricted stock units
@ $0 |
|
| 03/01/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/01/2016 |
4
| Shea Thomas A. (CFO) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 1,554 shares
@ $2.8, valued at
$4.4k
Exercised 1,044 restricted stock units
@ $0
Exercised 3,073 restricted stock units
@ $0 |
|
| 03/01/2016 |
4
| Munshi Amit (CEO) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 4,305 shares
@ $2.8, valued at
$12.1k
Exercised 1,519 restricted stock units
@ $0
Exercised 9,887 restricted stock units
@ $0 |
|
| 03/01/2016 |
4
| Wyand Michael (Chief Technical Officer) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 1,379 shares
@ $2.8, valued at
$3.9k
Exercised 1,044 restricted stock units
@ $0
Exercised 2,608 restricted stock units
@ $0 |
|
| 12/22/2015 |
4
| Ticktin Robert (General Counsel) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.|
Txns:
| Bought 3,000 shares
@ $3.7205, valued at
$11.2k
|
|
| 12/21/2015 |
4
| Vincent Aurentz (Chief Business Officer) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.|
Txns:
| Bought 2,200 shares
@ $3.43, valued at
$7.5k
|
|
| 12/17/2015 |
4
| Munshi Amit (CEO) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.|
Txns:
| Bought 8,270 shares
@ $2.8, valued at
$23.2k
|
|
| 12/16/2015 |
4
| Munshi Amit (CEO) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.|
Txns:
| Bought 8,069 shares
@ $2.87, valued at
$23.2k
|
|
| 12/11/2015 |
4
| Vincent Aurentz (Chief Business Officer) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.|
Txns:
| Bought 2,800 shares
@ $3.85, valued at
$10.8k
|
|
| 12/10/2015 |
4
| Munshi Amit (CEO) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.|
Txns:
| Bought 13,190 shares
@ $4.07, valued at
$53.7k
|
|
| 11/10/2015 |
4
| Vincent Aurentz (Chief Business Officer) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.|
Txns:
| Granted 219,487 options to buy
@ $5.21, valued at
$1.1M
|
|
| 11/03/2015 |
4
| Shea Thomas A. (CFO) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.|
Txns:
| Exercised 28,926 options to buy
@ $1.3, valued at
$37.6k
|
|
| 11/03/2015 |
4
| Ticktin Robert (General Counsel) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.|
Txns:
| Granted 39,474 options to buy
@ $5.55, valued at
$219.1k
|
|
| 11/03/2015 |
4
| Shea Thomas A. (CFO) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.|
Txns:
| Granted 56,842 options to buy
@ $5.55, valued at
$315.5k
|
|
| 11/03/2015 |
4
| Wyand Michael (Chief Technical Officer) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.|
Txns:
| Granted 58,247 options to buy
@ $5.55, valued at
$323.3k
|
|
| 11/03/2015 |
4
| Munshi Amit (CEO) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.|
Txns:
| Granted 199,537 options to buy
@ $5.55, valued at
$1.1M
|
|
| 09/22/2015 |
4
| Munshi Amit (CEO) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.|
Txns:
| Bought 10,000 shares
@ $6.19, valued at
$61.9k
|
|
| 09/21/2015 |
4
| Munshi Amit (CEO) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.|
Txns:
| Bought 10,000 shares
@ $5.986, valued at
$59.9k
|
|
| 09/14/2015 |
4
| Wyand Michael (Chief Technical Officer) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.|
Txns:
| Exercised 4,209 options to buy
@ $1, valued at
$4.2k
Exercised 4,538 options to buy
@ $1, valued at
$4.5k
|
|
| 07/06/2015 |
4
| Munshi Amit (CEO) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.|
Txns:
| Exercised 21,273 options to buy
@ $1, valued at
$21.3k
Exercised 7,246 options to buy
@ $1, valued at
$7.2k
Exercised 22,681 options to buy
@ $1, valued at
$22.7k
|
|
| 06/08/2015 |
4
| ROCKLAGE SCOTT M (10% Owner) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.|
Txns:
| Granted 9,000 options to buy
@ $6.39, valued at
$57.5k
|
|
| 06/08/2015 |
4
| McHugh Julie (Director) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.|
Txns:
| Granted 9,000 options to buy
@ $6.39, valued at
$57.5k
|
|
| 06/08/2015 |
4
| Hunter William L (Director) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc. |
| 06/08/2015 |
4
| Fu Daotian (Director) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.|
Txns:
| Granted 9,000 options to buy
@ $6.39, valued at
$57.5k
|
|
| 06/08/2015 |
4
| DUYK GEOFFREY M (Director) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc. |
| 06/08/2015 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc. |
| 06/08/2015 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc. |
| 04/03/2015 |
4
| Wyand Michael (Chief Technical Officer) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $8.4, valued at
$168k
|
|
| 03/02/2015 |
4
| Ticktin Robert (General Counsel) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.|
Txns:
| Granted 65,006 options to buy
@ $10.53, valued at
$684.5k
Granted 949 restricted stock units
@ $0
Granted 8,534 restricted stock units
@ $0 |
|
| 03/02/2015 |
4
| Wyand Michael (See Remarks) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.|
Txns:
| Granted 79,461 options to buy
@ $10.53, valued at
$836.7k
Granted 1,044 restricted stock units
@ $0
Granted 10,432 restricted stock units
@ $0 |
|
|
|
|